Acquired resistance in lung cancer

被引：0
|
作者：
Pamela Feliciano
机构：
来源：
Nature Genetics | 2012年 / 44卷 / 3期
关键词：
D O I：
10.1038/ng.2209
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 241
相关论文
共 50 条
  • [21] Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer
    Jacobsen, Kirstine
    Bertran-Alamillo, Jordi
    Angel Molina, Miguel
    Teixido, Cristina
    Karachaliou, Niki
    Pedersen, Martin Haar
    Castellvi, Josep
    Garzon, Monica
    Codony-Servat, Carles
    Codony-Servat, Jordi
    Gimenez-Capitan, Ana
    Drozdowskyj, Ana
    Viteri, Santiago
    Larsen, Martin R.
    Lassen, Ulrik
    Felip, Enriqueta
    Bivona, Trever G.
    Ditzel, Henrik J.
    Rosell, Rafael
    NATURE COMMUNICATIONS, 2017, 8
  • [22] Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo
    Zhongwei Liu
    Neal Shah
    Kent L. Marshall
    Samuel A. Sprowls
    Pushkar Saralkar
    Afroz Mohammad
    Kathryn E. Blethen
    Tasneem A. Arsiwala
    Ross Fladeland
    Paul R. Lockman
    Weimin Gao
    Archives of Toxicology, 2021, 95 : 3575 - 3587
  • [23] Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
    Yoshida, Ryohei
    Sasaki, Takaki
    Minami, Yoshinori
    Hibino, Yukiko
    Okumura, Shunsuke
    Sado, Masatoshi
    Miyokawa, Naoyuki
    Hayashi, Satoshi
    Kitada, Masahiro
    Ohsaki, Yoshinobu
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 51 (05) : 1533 - 1540
  • [24] Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells
    Liu, Zhongwei
    Gao, Weimin
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 335 : 16 - 27
  • [25] Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo
    Liu, Zhongwei
    Shah, Neal
    Marshall, Kent L.
    Sprowls, Samuel A.
    Saralkar, Pushkar
    Mohammad, Afroz
    Blethen, Kathryn E.
    Arsiwala, Tasneem A.
    Fladeland, Ross
    Lockman, Paul R.
    Gao, Weimin
    ARCHIVES OF TOXICOLOGY, 2021, 95 (11) : 3575 - 3587
  • [26] Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
    Yoshida, Ryohei
    Sasaki, Takaaki
    Okumura, Shunsuke
    Ohsaki, Yoshinobu
    CANCER RESEARCH, 2017, 77
  • [27] Acquired resistance to cancer immunotherapy
    Draghi, Arianna
    Chamberlain, Christopher Aled
    Furness, Andrew
    Donia, Marco
    SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (01) : 31 - 40
  • [28] Acquired resistance to cancer immunotherapy
    Arianna Draghi
    Christopher Aled Chamberlain
    Andrew Furness
    Marco Donia
    Seminars in Immunopathology, 2019, 41 : 31 - 40
  • [29] Characterising acquired resistance to erlotinib in non-small cell lung cancer patients
    Karachaliou, Niki
    Codony-Servat, Jordi
    Paulina Bracht, Jillian Wilhelmina
    Ito, Masaoki
    Filipska, Martyna
    Pedraz, Carlos
    Chaib, Imane
    Bertran-Alamillo, Jordi
    Felipe Cardona, Andres
    Angel Molina, Miguel
    Rosell, Rafael
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (10) : 1019 - 1028
  • [30] GENETIC ALTERATIONS AND CELLULAR PROPERTIES OF ACQUIRED ARSENIC RESISTANCE IN SMALL CELL LUNG CANCER
    Zheng, Chun Yan
    Lam, Sze Kwan
    Li, Yuan Yuan
    Ho, James Chung Man
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1041 - S1041
12345